Research Article

Hyperprogressive Disease Caused by PD-1 Inhibitors for the Treatment of Pan-Cancer

Figure 2

Blue spots show 339 patients with nonhyperprogressing disease (non-HPD). Red spots show 38 patients with hyperprogressive disease (HPD) during PD-1 inhibitor therapy.